Patent · US Active

Method for treating and/or preventing retinal diseases with sustained release corticosteroids

US8252307B2 · kind B2 · utility

9Cited by
155References
25Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJan 8, 2010
Grant dateAug 28, 2012
Priority date
Expiry dateApr 15, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a method for administering a corticosteroid to a posterior segment of an eye. In the method, a sustained release device is implanted to deliver the corticosteroid to the eye. The aqueous corticosteroid concentration remains less than vitreous corticosteroid concentration during release of the corticosteroid from the device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.